Citations

Clear

11 citation(s) found for "Messmann, H".

Correlative Biomarker Analysis of PSMA Expression on CTCs and PSMA Imaging in a Phase I Study of PSMA-Targeted Tubulysin Conjugate EC1169
Zaidi, Samir , Kuo, Phillip H. , Prudente, Tiago Paiva, Lacuna, Kristine P. , Babiker, Hani M., Aparicio, Renan , Schonhoft, Joseph D. , Fernandez, Luisa , Messmann, Richard , Groaning, Michael , Tolcher, Anthony W., Gordon, Michael S. , Yoo, Don C. , Vaishampayan, Ulka, Petrylak, Daniel P., Sartor, Oliver, Morris, Michael J., Vaishampayan, Ulka N. , Babiker, Hani M. , Kuo, Phillip H. , Messmann, Richard A. , Lacuna, Kristine Peregrino , Paiva Prudente, Tiago , Babiker, Hani , Tolcher, Anthony W. , Vaishampayan, Ulka , Picus, Joel , Petrylak, Daniel P , Sartor, A Oliver , Morris, Michael J , Groaning, Michael D., Picus, Joel , Petrylak, Daniel P. , Morris, Michael J.

Mayo Clinic

Clinical Cancer Research | January 27, 2026 | Volume: 32 | Issue: 9 | Pages: 1766-1776

10.1158/1078-0432.ccr-25-2313 | PMID 41591990 Get It

Abstract Purpose: Prostate-specific membrane antigen (PSMA)–directed therapies provide meaningful clinical benefit in metastatic castration-resistant prostate cancer (mCRPC), yet responses remain limited, underscoring the need for additional biomarkers of PSMA expression heterogeneity. In this study, we explored the relationship between PSMA imaging and PSMA expression on circulating tumor cells (CTC) in our early-phase trial using a PSMA-targeted small molecule. Experimental Design: This phase I study investigated EC1169, a small molecule conjugated to a tubulysin analog warhead, and 99mTc–EC0652, a PSMA imaging agent. Part A (dose escalation) identified the recommended phase II dose. Part B (dose expansion) assessed radiographic progression-free survival (rPFS) as its primary endpoint. We enrolled and treated 103 patients with mCRPC. Most part B patients underwent 99mTc–EC0652 PSMA imaging. A CTC assay assessed PSMA-positive CTCs and their association with response and PSMA imaging. Results: 99mTc–EC0652 single-photon emission computed tomography (SPECT) imaging demonstrated increased sensitivity for detecting bone lesions compared with standard scans (computed tomography/bone scans). Using an optimized CTC assay, we observed that patients with a decrease in PSMA+ CTCs at baseline versus C3D1 displayed a longer rPFS (8 vs. 2.9 months; P = 0.04). Importantly, patients with predominantly PSMA-positive disease on 99mTc–EC0652 imaging also harbored PSMA-negative CTCs, with a subset displaying neuroendocrine prostate cancer–like morphology. Conclusions: Although EC1169 showed limited activity, CTC and imaging analyses showed significant heterogeneity in PSMA expression on CTCs in patients with predominantly PSMA-positive lesions on SPECT. Our study highlights the importance of assessing both PSMA-based CTC and imaging assays in future validation trials.
Artificial Intelligence‐assisted Endoscopy and Examiner Confidence: A Study on Human–Artificial Intelligence Interaction in Barrett's Esophagus (With Video)
Röser, D, Meinikheim, M. , Mendel, Robert , Nagl, Sandra , Scheppach, Markus W. , Römmele, Christoph , Schnoy, Elisabeth , Parsa, Nasim , Byrne, Michael F., Messmann, H, Ebigbo, Alanna , Roser, David , Römmele, Christoph , Muzalyova, Anna , Palm, Christoph , Probst, Andreas

Mayo Clinic

DEN Open | June 19, 2025 | Volume: 6 | Issue: 1 | Pages: No page available

10.1002/deo2.70150 | PMID 40548292 Get It

ABSTRACT Objective Despite high stand‐alone performance, studies demonstrate that artificial intelligence (AI)‐supported endoscopic diagnostics often fall short in clinical applications due to human‐AI interaction factors. This video‐based trial on Barrett's esophagus aimed to investigate how examiner behavior, their levels of confidence, and system usability influence the diagnostic outcomes of AI‐assisted endoscopy. Methods The present analysis employed data from a multicenter randomized controlled tandem video trial involving 22 endoscopists with varying degrees of expertise. Participants were tasked with evaluating a set of 96 endoscopic videos of Barrett's esophagus in two distinct rounds, with and without AI assistance. Diagnostic confidence levels were recorded, and decision changes were categorized according to the AI prediction. Additional surveys assessed user experience and system usability ratings. Results AI assistance significantly increased examiner confidence levels ( p < 0.001) and accuracy. Withdrawing AI assistance decreased confidence ( p < 0.001), but not accuracy. Experts consistently reported higher confidence than non‐experts ( p < 0.001), regardless of performance. Despite improved confidence, correct AI guidance was disregarded in 16% of all cases, and 9% of initially correct diagnoses were changed to incorrect ones. Overreliance on AI, algorithm aversion, and uncertainty in AI predictions were identified as key factors influencing outcomes. The System Usability Scale questionnaire scores indicated good to excellent usability, with non‐experts scoring 73.5 and experts 85.6. Conclusions Our findings highlight the pivotal function of examiner behavior in AI‐assisted endoscopy. To fully realize the benefits of AI, implementing explainable AI, improving user interfaces, and providing targeted training are essential. Addressing these factors could enhance diagnostic accuracy and confidence in clinical practice.
Computer‐aided detection for esophageal achalasia (with video)
Shiwaku, Hironari , Misawa, Masashi , Inoue, Haruhiro , Boškoski, Ivo , Shimamura, Yuto , Ikebuchi, Yuichiro , Ominami, Masaki , Htet, Hein , Messmann, H, Colosso, Bianca Maria Quarta , Repici, Alessandro , Stavropoulos, Stavros N. , Bechara, Robert , Sethi, Amrita, Beyna, Torsten , Santi, Esperanza Grace , Sharma, Prateek , Eleftheriadis, Nikolas, Minami, Hitomi, Haber, Gregory , Seewald, Stefan , Shiwaku, Akio, Shiwaku, Yoshiyuki, Mori, Kensaku, Costamagna, Guido , Shimamura, Yuto , Ikebuchi, Yuichiro , Iwaya, Yugo , Htet, Hein Myat Thu , Colosso, Bianca Maria Quarta , Bechara, Robert , Kahaleh, Michel , Beyna, Torsten , Jiang, Kai, Oda, Masahiro , Familiari, Pietro , Hayee, Bu , Ho, Khek Yu , So, Jimmy Bok Yan , Bhandari, Pradeep , Grimes, Kevin L. , Maselli, Roberta , Hassan, Cesare , Fukami, Norio , Kahaleh, Michel , Sethi, Amrita , Neuhaus, Horst Ekkehard , Chiu, Philip Wai Yan , Eleftheriadis, Nikolas, Draganov, Peter V. , Mori, Kensaku , Kudo, Shin‐ei , Hasegawa, Suguru

Mayo Clinic

Digestive Endoscopy | June 12, 2025 | Volume: 37 | Issue: 8 | Pages: 851-861

10.1111/den.15028 | PMID 40506418 Get It

ObjectivesAchalasia is an esophageal motility disorder that impairs quality of life and is often missed (20–50%) on endoscopy. A newly developed computer‐aided detection (CAD) software has shown high accuracy for achalasia diagnosis in preclinical settings. However, its benefit in a clinical setting remains unclear.MethodsBetween February and August 2023, 83 endoscopists from 27 centers assessed 50 randomized endoscopic videos (25 achalasia, 25 nonachalasia) without and with CAD. Endoscopists assessed videos without CAD, then with CAD after 2 months. The primary end‐point was improvement in sensitivity for nonexperienced endoscopists (no endoscopic experience of achalasia). Sensitivity, specificity, and accuracy with and without CAD were compared using the McNemar test.ResultsSensitivity for diagnosing achalasia increased significantly with CAD, rising from 74.2% (95% confidence interval [CI] 72.2–76.0%) to 91.2% (95% CI 89.9–92.4%) for all readers, showing a difference of 17.1% (95% CI 15.1–19.0%). Specifically, sensitivity improved from 66.9% (95% CI 63.6–70.0%) to 91.9% (95% CI 89.9–93.6%) among nonexperienced endoscopists, resulting in a difference of 25.0% (95% CI 21.7–28.4%), and from 79.5% (95% CI 77.1–81.8%) to 90.8% (95% CI 89.0–92.3%) among experienced endoscopists (endoscopic experience of at least one achalasia case), with a difference of 11.3% (95% CI 8.9–13.6%). Accuracy and specificity improved significantly with CAD assistance, regardless of reader's experience.ConclusionCAD improves achalasia detection by 17%, confirming preclinical results. The benefit was higher for nonexperienced endoscopists. CAD assistance may lead to prompt and effective treatment, minimizing the risk of false‐negative diagnosis in clinical practice.Trial registrationThis study was registered in the University Hospital Medical Information Network Clinical Trial Registry (https://www.umin.ac.jp/ctr/) number: UMIN000053047.
International Validation of a Novel PEACE Scale to Improve the Quality of Upper Gastrointestinal Mucosal Inspection During Endoscopy
Romańczyk, Marcin , Desai, Madhav , Abe, Seiichiro , Alkandari, Asma , Beyna, Torsten , Bisschops, Raf , Budzyń, Krzysztof , Grover, Samir C. , Gyawali, C. Prakash, Inoue, Haruhiro , Iyer, Prasad G. , Srinivasan, Sachin , Gyawali, C. Prakash , Hassan, Cesare , Gyawali, C P , Hassan, Cesare , Bisschops, Raf , Grover, Samir C , Kaminski, Michal Filip , Bugdol, Monika Natalia , Messmann, Helmut , Ragunath, Krish , Saito, Yutaka , Teshima, Christopher , Yadlapati, Rena , Sharma, Prateek

Mayo Clinic

Clinical and Translational Gastroenterology | November 14, 2024 | Volume: 16 | Issue: 1 | Pages: e00786

10.14309/ctg.0000000000000786 | PMID 39853720 Get It

INTRODUCTION: The performance of a high quality esophagogastroduodenoscopy (EGD) is dependent on the mucosal cleanliness. Recently, the Polprep: Effective Assessment of Cleanliness in EGD (PEACE) scale was created to assess the degree of mucosal cleanliness during EGD. The aim of this study was to validate this scoring system in a cohort of international endoscopists. METHODS: In total, 39 EGD videos, with different degrees of mucosal cleanliness were retrieved from a previously conducted prospective trial. All experts rated the cleanliness of the mucosa on each video using the PEACE scale. To evaluate agreement of all scores (0–3), intraclass correlation coefficient 2.1 was used. The agreement on adequate (scores 2 and 3) and inadequate (scores 0 and 1) cleanliness was assessed using kappa values. RESULTS: Videos evaluating esophagus, stomach, and duodenum cleanliness were reviewed by 16 endoscopists. The PEACE scores demonstrated good agreement (intraclass correlation coefficient 0.82, 95% CI 0.75–0.89), especially for esophagus (0.84; 95% CI 0.71–0.95) and stomach (0.81; 95% CI 0.69–0.91), while agreement was moderate for the duodenum (0.69; 95% CI 0.51–0.87). The agreement was similar between Eastern (0.86; 95% CI 0.79–0.92) and Western experts (0.80; 95% CI 0.72–0.88). Similarly, agreement regarding adequate cleanliness was comparable between Eastern (0.70; 95% CI 0.55–0.85) and Western (0.74; 95% CI 0.64–0.84) endoscopists being overall 0.75 (95% CI 0.65–0.85). DISCUSSION: The PEACE scoring system is a simple and reliable scale to assess the cleanliness during EGD. The score is now validated among international experts with high concordance, justifying its use in clinical practice.
Mensch-Maschine-Interaktion: Einfluss künstlicher Intelligenz auf das diagnostische Vertrauen von Endoskopikern bei der Beurteilung des Barrett-Ösophagus
Röser, D, Meinikheim, M. , Mendel, Rosmarie, Palm, Christian, Rauber, David , Rückert, Tobias, Parsa, Nasim , Ebigbo, Alanna , Roser, D., Mendel, R., Muzalyova, Anna , Byrne, M., Messmann, Helmut

Mayo Clinic

Zeitschrift für Gastroenterologie | October 2, 2024 | Volume: 62 | Issue: 09 | Pages: e575-e576

10.1055/s-0044-1789656 Get It

Can optical evaluation distinguish between T1a and T1b esophageal adenocarcinoma: an international expert interobserver agreement study
Gupta, Sunil , Mandarino, Francesco Vito , Hourigan, Luke F. , Messmann, Helmut , Wallace, Michael B. , Repici, Alessandro , Haber, Gregory , Taylor, Andrew C.F., Waxman, Irving , Siersema, Peter D. , Lemmers, Arnaud , Bisschops, Raf , Mosko, Jeffrey D. , Pech, Oliver , Beyna, Torsten , Sharma, Prateek , Lee, Eric Y.T., Bourke, Michael J., group, on behalf of the study working, Bourke, Michael J. , Shahidi, Neal , Wallace, Michael B , Bisschops, Raf , Beyna, Torsten , Burgess, Nicholas G , Mandarino, Francesco Vito , Gupta, Sunil , Dinis‐Ribeiro, Mário , Pouw, Roos E. , Teshima, Christopher , Ragunath, Krish , Rösch, Thomas , group, on behalf of the study working

Mayo Clinic

Endoscopy | August 21, 2024 | Volume: 57 | Issue: 03 | Pages: 200-207

10.1055/a-2399-1401 | PMID 39168143 Get It

Background Piecemeal endoscopic mucosal resection (EMR) is an acceptable technique for T1a esophageal adenocarcinoma, but en bloc R0 excision is advocated for T1b disease as it may offer a potential cure and mitigate recurrence. Thus, distinguishing between T1a and T1b disease is imperative under current treatment paradigms. We investigated whether expert Barrett’s endoscopists could make this distinction based on optical evaluation. Methods Endoscopic images of histologically confirmed high grade dysplasia (HGD), T1a, and T1b disease (20 sets for each) were compiled from consecutive patients at a single institution. Each set contained four images including an overview, a close-up in high definition white light, a near-focus magnification image, and a narrow-band image. Experts predicted the histology for each set. Results 19 experts from 8 countries (Australia, USA, Italy, Netherlands, Germany, Canada, Belgium, and Portugal) participated. The majority had been practicing for > 20 years, with a median (interquartile range) annual case volume of 50 (18–75) for Barrett’s EMR and 25 (10–45) for Barrett’s endoscopic submucosal dissection. Esophageal adenocarcinoma (T1a/b) could be distinguished from HGD with a pooled sensitivity of 89.1 % (95 %CI 84.7–93.4). T1b adenocarcinoma could be predicted with a pooled sensitivity of 43.8 % (95 %CI 29.9–57.7). Fleiss’ kappa was 0.421 (95 %CI 0.399–0.442; P < 0.001), indicating fair-to-moderate agreement. Conclusions Expert Barrett’s endoscopists could reliably differentiate T1a/T1b esophageal adenocarcinoma from HGD. Despite fair-to-moderate agreement for T staging, T1b disease could not be reliably distinguished from T1a disease. This may impact clinical decision making and selection of endoscopic techniques.
International consensus on the management of large (≥20 mm) colorectal laterally spreading tumors: World Endoscopy Organization Delphi study
Rex, Douglas K. , Aihara, Hiroyuki , Bastiaansen, Barbara A.J. , Bechara, Robert , Bhatt, Amit , Bourke, Michael J. , Byeon, Jeong‐Sik , Chino, Akiko , Goldblum, John R. , Ho, Shiaw Hooi , Jung, Yunho , Kawachi, Hiroshi , Khashab, Mouen A., Khomvilai, Supakij , Messmann, Helmut , Mori, Yuichi, Nakanishi, Yukihiro , Ngamruengphong, Saowanee , Parra‐Blanco, Adolfo , Pinto, Rafael Castilho , Pioche, Mathieu , Pohl, Heiko , Rastogi, Amit , Repici, Alessandro , Sethi, Amrita , Suzuki, Noriko, Tanaka, Shinji , Vieth, Michael, Yokoi, Chizu , Saito, Yutaka , Renteln, Daniel von , Chino, Akiko , Chiu, Philip Wai Yan , Elkholy, Shaimaa , Kawachi, Hiroshi , Yamamoto, Hironori , Yang, Dong-Hoon , Saito, Yutaka , Bhatt, Amit , Bechara, Robert , Djinbachian, Roupen , Chiu, Han‐Mo , Fukami, Norio , Bhandari, Pradeep , Cardoso, Daniela, Dekker, Evelien , Draganov, Peter V. , Emura, Fabian , Haji, Amyn , Khashab, Mouen A. , Kim, Eun Ran , Maselli, Roberta , Moons, Leon M.G. , Pellisé, Maria , Singh, Rajvinder

Mayo Clinic

Digestive Endoscopy | June 27, 2024 | Volume: 36 | Issue: 11 | Pages: 1253-1268

10.1111/den.14826 | PMID 38934243 Get It

ObjectivesThere have been significant advances in the management of large (≥20 mm) laterally spreading tumors (LSTs) or nonpedunculated colorectal polyps; however, there is a lack of clear consensus on the management of these lesions with significant geographic variability especially between Eastern and Western paradigms. We aimed to provide an international consensus to better guide management and attempt to homogenize practices.MethodsTwo experts in interventional endoscopy spearheaded an evidence‐based Delphi study on behalf of the World Endoscopy Organization Colorectal Cancer Screening Committee. A steering committee comprising six members devised 51 statements, and 43 experts from 18 countries on six continents participated in a three‐round voting process. The Grading of Recommendations, Assessment, Development and Evaluations tool was used to assess evidence quality and recommendation strength. Consensus was defined as ≥80% agreement (strongly agree or agree) on a 5‐point Likert scale.ResultsForty‐two statements reached consensus after three rounds of voting. Recommendations included: three statements on training and competency; 10 statements on preresection evaluation, including optical diagnosis, classification, and staging of LSTs; 14 statements on endoscopic resection indications and technique, including statements on en bloc and piecemeal resection decision‐making; seven statements on postresection evaluation; and eight statements on postresection care.ConclusionsAn international expert consensus based on the current available evidence has been developed to guide the evaluation, resection, and follow‐up of LSTs. This may provide guiding principles for the global management of these lesions and standardize current practices.
Human-Computer Interaction: Impact of Artificial Intelligence on the diagnostic confidence of endoscopists assessing videos of Barrett’s esophagus
Röser, D, Meinikheim, M. , Mendel, Robert , Scheppach, Markus W. , Nagl, Sandra , Schnoy, Elisabeth , Schulz, Dominik , Schlottmann, J., Prinz, F., Rauber, David , Rückert, Tobias, Parsa, Nour, Messmann, H, Ebigbo, Alanna , Roser, David , Palm, Christoph , Probst, Andreas , Muzalyova, Anna , Römmele, Christoph , Matsumura, Tomoaki , Fernández‐Esparrach, Glòria , Byrne, Michael F.

Mayo Clinic

Endoscopy | April 23, 2024 | Volume: 56 | Issue: S 02 | Pages: S79-S79

10.1055/s-0044-1782859 Get It

International validation of a PEACE scale assessing cleanliness during esophagogastroduodenoscopy to improve the quality of inspection during endoscopy
Romańczyk, Monika , Desai, Madhav , Abe, Seiichiro , Alkandari, Asma , Beyna, Torsten , Budzyń, Krzysztof , Grover, Samir C. , Gyawali, P. , Iyer, Prasad G. , Srinivasan, Sachin , Grover, Samir C , Kaminski, Michal Filip , Bisschops, Raf , Bugdol, Marcin Dominik , Gyawali, P., Inoue, H., Messmann, Helmut , Ragunath, Krish , Saito, Yutaka , Teshima, Christopher , Yadlapati, Rena , Hassan, Cesare , Sharma, Prateek

Mayo Clinic

Endoscopy | April 23, 2024 | Volume: 56 | Issue: S 02 | Pages: S27-S28

10.1055/s-0044-1782743 Get It

Influence of artificial intelligence on the diagnostic performance of endoscopists in the assessment of Barrett’s esophagus: a tandem randomized and video trial
Meinikheim, M. , Mendel, Robert , Scheppach, Markus W. , Nagl, Sandra , Schnoy, Elisabeth , Römmele, Christoph , Schulz, Dominik , Schlottmann, J., Prinz, Friederike, Rauber, David , Rückert, Tobias, Parsa, Nasim , Messmann, Helmut , Ebigbo, Alanna , Meinikheim, Michael , Römmele, Christoph , Matsumura, Tomoaki , Palm, Christoph , Probst, Andreas , Muzalyova, Anna , Fernández‐Esparrach, Glòria , Byrne, Michael F.

Mayo Clinic

Endoscopy | March 29, 2024 | Volume: 56 | Issue: 09 | Pages: 641-649

10.1055/a-2296-5696 | PMID 38547927 Get It

Abstract Background This study evaluated the effect of an artificial intelligence (AI)-based clinical decision support system on the performance and diagnostic confidence of endoscopists in their assessment of Barrett’s esophagus (BE). Methods 96 standardized endoscopy videos were assessed by 22 endoscopists with varying degrees of BE experience from 12 centers. Assessment was randomized into two video sets: group A (review first without AI and second with AI) and group B (review first with AI and second without AI). Endoscopists were required to evaluate each video for the presence of Barrett’s esophagus-related neoplasia (BERN) and then decide on a spot for a targeted biopsy. After the second assessment, they were allowed to change their clinical decision and confidence level. Results AI had a stand-alone sensitivity, specificity, and accuracy of 92.2%, 68.9%, and 81.3%, respectively. Without AI, BE experts had an overall sensitivity, specificity, and accuracy of 83.3%, 58.1%, and 71.5%, respectively. With AI, BE nonexperts showed a significant improvement in sensitivity and specificity when videos were assessed a second time with AI (sensitivity 69.8% [95%CI 65.2%–74.2%] to 78.0% [95%CI 74.0%–82.0%]; specificity 67.3% [95%CI 62.5%–72.2%] to 72.7% [95%CI 68.2%–77.3%]). In addition, the diagnostic confidence of BE nonexperts improved significantly with AI. Conclusion BE nonexperts benefitted significantly from additional AI. BE experts and nonexperts remained significantly below the stand-alone performance of AI, suggesting that there may be other factors influencing endoscopists’ decisions to follow or discard AI advice.